Effects of pre-radiation exposure to LLLT of normal and malignant cells

Supportive Care in Cancer

Volumn 24, Issue 6, 2016, Pages 2497-2501

  Barasch, Andrei ^a,b   Raber Durlacher, Judith ^b   Epstein, Joel B ^c,d   Carroll, James ^e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e THOR Photomedicine Ltd   (United Kingdom)

Author keywords

Cancer; Cytoprotection; LLLT; Mucositis

Indexed keywords

ARTICLE; CANCER CELL; CELL GROWTH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IONIZING RADIATION; LEUKEMIA CELL; LOW LEVEL LASER THERAPY; LYMPHOBLAST; ORAL MUCOSITIS; PRIORITY JOURNAL; RADIATION EXPOSURE; CELL LINE; HL-60 CELL LINE; LEUKEMIA; LYMPHOCYTE; PATHOLOGY; PROCEDURES; RADIATION RESPONSE; STOMATITIS;

CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HL-60 CELLS; HUMANS; LASER THERAPY; LEUKEMIA; LOW-LEVEL LIGHT THERAPY; LYMPHOCYTES; STOMATITIS;

EID: 84949970934     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-3051-8     Document Type: Article

References (15)

1. Elting LS, Keefe DM, Sonis ST et al (2008) Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy. Cancer 113:2704–2713
2. Barasch A, Coke JM (2007) Cancer therapeutics: an update on its effects on oral health. Periodontology 2000 44:44–54
3. Lalla RV, Bowen J, Barasch A et al (2014) MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 121:1453–1461
4. Clarkson JE, Worthington HV, Furness S et al (2010) Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. Issue 8. Art. No.: CD001973
5. Bjordal JM, Bensadoun RJ, Tuner J et al (2011) A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis (OM). Support Care Cancer 19:1069–1077
6. Jenkins PA, Carroll JD (2011) How to report low-level laser therapy (LLLT)/photomedicine dose and beam parameters in clinical and laboratory studies. Photomed Laser Surg 29:785–787
7. Barasch A, Peterson DE, Tanzer JM et al (1995) Helium-Neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients. Cancer 76:2550–2556
8. Schartinger VH, Galvan O, Riechelmann H, Dudas J (2012) Differential responses of fibroblasts, non-neoplastic epithelial cells, and oral carcinoma cells to low-level laser therapy. Support Care Cancer 20:523–529
9. Sperandio FF, Giudice FS, Correa L et al (2013) Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway. J Biophotonics 6:839–847
10. Kreisler M, Christoffers AB, Willershausen B, D’Hoedt B (2003) Low level 809 nm GaAlAs laser irradiation increases the proliferation rate of human laryngeal carcinoma cells in vitro. Lasers Med Sci 18:100–103
11. Eells JT, Wong-Riley MT, Verhoeve J et al (2004) Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion 4:559–567
12. Chen AC, Arany PR, Huang YY et al (2011) Low-level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embryonic fibroblasts. PLoS One 6:e22453
13. Arany PR, Nayak RS, Hallikerimath S et al (2007) Activation of latent TGF-beta1 by low-power laser in vitro correlates with increased TGF-beta1 levels in laser-enhanced oral wound healing. Wound Repair Regen 15:866–874
14. Lopes NNF, Plapler H, Chavantes MC et al (2009) Cyclooxygenase-2 and vascular endothelial growth factor expression in 5-fluorouracil-induced oral mucositis in hamsters: evaluation of two low-intensity laser protocols. Support Care Cancer 17:1409–1415
15. Antunes HS, Herchenhorn D, Small IA et al (2013) Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiother Oncol 109:297–302